101 related articles for article (PubMed ID: 36719241)
21. Nanoparticles in influenza subunit vaccine development: Immunogenicity enhancement.
Khalaj-Hedayati A; Chua CLL; Smooker P; Lee KW
Influenza Other Respir Viruses; 2020 Jan; 14(1):92-101. PubMed ID: 31774251
[TBL] [Abstract][Full Text] [Related]
22. Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines.
Rak A; Isakova-Sivak I; Rudenko L
Vaccines (Basel); 2023 Nov; 11(12):. PubMed ID: 38140152
[TBL] [Abstract][Full Text] [Related]
23. Trimeric, APC-Targeted Subunit Vaccines Protect Mice against Seasonal and Pandemic Influenza.
Tjärnhage E; Brown D; Bogen B; Andersen TK; Grødeland G
J Virol; 2023 Feb; 97(2):e0169422. PubMed ID: 36719241
[TBL] [Abstract][Full Text] [Related]
24. A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza.
Andersen TK; Zhou F; Cox R; Bogen B; Grødeland G
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931687
[TBL] [Abstract][Full Text] [Related]
25. A plant-produced H1N1 trimeric hemagglutinin protects mice from a lethal influenza virus challenge.
Shoji Y; Jones RM; Mett V; Chichester JA; Musiychuk K; Sun X; Tumpey TM; Green BJ; Shamloul M; Norikane J; Bi H; Hartman CE; Bottone C; Stewart M; Streatfield SJ; Yusibov V
Hum Vaccin Immunother; 2013 Mar; 9(3):553-60. PubMed ID: 23296194
[TBL] [Abstract][Full Text] [Related]
26. Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques.
Florek KR; Weinfurter JT; Jegaskanda S; Brewoo JN; Powell TD; Young GR; Das SC; Hatta M; Broman KW; Hungnes O; Dudman SG; Kawaoka Y; Kent SJ; Stinchcomb DT; Osorio JE; Friedrich TC
J Virol; 2014 Nov; 88(22):13418-28. PubMed ID: 25210172
[TBL] [Abstract][Full Text] [Related]
27. Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin.
Brazzoli M; Magini D; Bonci A; Buccato S; Giovani C; Kratzer R; Zurli V; Mangiavacchi S; Casini D; Brito LM; De Gregorio E; Mason PW; Ulmer JB; Geall AJ; Bertholet S
J Virol; 2016 Jan; 90(1):332-44. PubMed ID: 26468547
[TBL] [Abstract][Full Text] [Related]
28. Pandemic Preparedness Against Influenza: DNA Vaccine for Rapid Relief.
Andersen TK; Bodin J; Oftung F; Bogen B; Mjaaland S; Grødeland G
Front Immunol; 2021; 12():747032. PubMed ID: 34691056
[TBL] [Abstract][Full Text] [Related]
29. Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line.
Aldén M; Olofsson Falla F; Yang D; Barghouth M; Luan C; Rasmussen M; De Marinis Y
Curr Issues Mol Biol; 2022 Feb; 44(3):1115-1126. PubMed ID: 35723296
[TBL] [Abstract][Full Text] [Related]
30. Metal-Organic Coordination Polymer for Delivery of a Subunit Broadly Acting Influenza Vaccine.
Eckshtain-Levi M; Batty CJ; Lifshits LM; McCammitt B; Moore KM; Amouzougan EA; Stiepel RT; Duggan E; Ross TM; Bachelder EM; Ainslie KM
ACS Appl Mater Interfaces; 2022 Jun; 14(25):28548-28558. PubMed ID: 35704854
[TBL] [Abstract][Full Text] [Related]
31. Multimericity Amplifies the Synergy of BCR and TLR4 for B Cell Activation and Antibody Class Switching.
Pone EJ; Hernandez-Davies JE; Jan S; Silzel E; Felgner PL; Davies DH
Front Immunol; 2022; 13():882502. PubMed ID: 35663959
[TBL] [Abstract][Full Text] [Related]
32. Antigen bivalency of antigen-presenting cell-targeted vaccines increases B cell responses.
Hinke DM; Andersen TK; Gopalakrishnan RP; Skullerud LM; Werninghaus IC; Grødeland G; Fossum E; Braathen R; Bogen B
Cell Rep; 2022 May; 39(9):110901. PubMed ID: 35649357
[TBL] [Abstract][Full Text] [Related]
33. Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination.
Röltgen K; Nielsen SCA; Silva O; Younes SF; Zaslavsky M; Costales C; Yang F; Wirz OF; Solis D; Hoh RA; Wang A; Arunachalam PS; Colburg D; Zhao S; Haraguchi E; Lee AS; Shah MM; Manohar M; Chang I; Gao F; Mallajosyula V; Li C; Liu J; Shoura MJ; Sindher SB; Parsons E; Dashdorj NJ; Dashdorj ND; Monroe R; Serrano GE; Beach TG; Chinthrajah RS; Charville GW; Wilbur JL; Wohlstadter JN; Davis MM; Pulendran B; Troxell ML; Sigal GB; Natkunam Y; Pinsky BA; Nadeau KC; Boyd SD
Cell; 2022 Mar; 185(6):1025-1040.e14. PubMed ID: 35148837
[TBL] [Abstract][Full Text] [Related]
34. Systematic review of the efficacy, effectiveness and safety of MF59
O Murchu E; Comber L; Jordan K; Hawkshaw S; Marshall L; O'Neill M; Ryan M; Teljeur C; Carnahan A; Pérez JJ; Robertson AH; Johansen K; Jonge J; Krause T; Nicolay N; Nohynek H; Pavlopoulou I; Pebody R; Penttinen P; Soler-Soneira M; Wichmann O; Harrington P
Rev Med Virol; 2023 May; 33(3):e2329. PubMed ID: 35142401
[TBL] [Abstract][Full Text] [Related]
35. Systematic review of the efficacy, effectiveness and safety of high-dose seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age.
Comber L; O Murchu E; Jordan K; Hawkshaw S; Marshall L; O'Neill M; Teljeur C; Ryan M; Carnahan A; Pérez Martín JJ; Robertson AH; Johansen K; de Jonge J; Krause T; Nicolay N; Nohynek H; Pavlopoulou I; Pebody R; Penttinen P; Soler-Soneira M; Wichmann O; Harrington P
Rev Med Virol; 2023 May; 33(3):e2330. PubMed ID: 35119149
[TBL] [Abstract][Full Text] [Related]
36. pH-Dependent Mechanisms of Influenza Infection Mediated by Hemagglutinin.
Caffrey M; Lavie A
Front Mol Biosci; 2021; 8():777095. PubMed ID: 34977156
[TBL] [Abstract][Full Text] [Related]
37. India's DNA COVID vaccine is a world first - more are coming.
Mallapaty S
Nature; 2021 Sep; 597(7875):161-162. PubMed ID: 34475553
[No Abstract] [Full Text] [Related]
38. A comprehensive analysis of the efficacy and safety of COVID-19 vaccines.
Cai C; Peng Y; Shen E; Huang Q; Chen Y; Liu P; Guo C; Feng Z; Gao L; Zhang X; Gao Y; Liu Y; Han Y; Zeng S; Shen H
Mol Ther; 2021 Sep; 29(9):2794-2805. PubMed ID: 34365034
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
